Enfusion, Inc.
ENFN
$10.76
-$0.04-0.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.82M | 3.33M | 3.74M | 2.54M | 6.03M |
| Total Depreciation and Amortization | 6.55M | 7.32M | 7.38M | 6.99M | 6.59M |
| Total Amortization of Deferred Charges | 5.43M | 4.95M | 4.40M | 3.95M | 3.49M |
| Total Other Non-Cash Items | 27.74M | 27.06M | 27.14M | 24.75M | 18.97M |
| Change in Net Operating Assets | -7.87M | -11.06M | -15.12M | -11.98M | -9.44M |
| Cash from Operations | 34.68M | 31.60M | 27.54M | 26.24M | 25.63M |
| Capital Expenditure | -3.64M | -3.95M | -3.80M | -3.60M | -4.45M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.26M | -9.58M | -9.55M | -6.27M | -5.22M |
| Cash from Investing | -13.89M | -13.52M | -13.36M | -9.87M | -9.67M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.00K | 19.00K | 7.65M | 17.32M | 17.32M |
| Repurchase of Common Stock | -1.29M | -1.87M | -13.64M | -54.14M | -60.45M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -136.00K | -136.00K | -1.29M | -1.29M | 42.00K |
| Cash from Financing | -1.40M | -1.98M | -7.28M | -38.10M | -43.08M |
| Foreign Exchange rate Adjustments | -511.00K | 558.00K | -230.00K | 25.00K | 179.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.88M | 16.65M | 6.68M | -21.70M | -26.94M |